BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 287 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $407,000 | -21.0% | 2,691 | -23.9% | 0.00% | 0.0% |
| Q2 2022 | $515,000 | -82.9% | 3,534 | -8.1% | 0.00% | -83.3% |
| Q1 2022 | $3,017,000 | +483.6% | 3,847 | +2.7% | 0.01% | +500.0% |
| Q4 2021 | $517,000 | +5.3% | 3,746 | +6.1% | 0.00% | 0.0% |
| Q3 2021 | $491,000 | +122.2% | 3,532 | +55.3% | 0.00% | – |
| Q2 2021 | $221,000 | +51.4% | 2,275 | +6.4% | 0.00% | – |
| Q1 2021 | $146,000 | +97.3% | 2,138 | +148.6% | 0.00% | – |
| Q4 2020 | $74,000 | +164.3% | 860 | +111.8% | 0.00% | – |
| Q3 2020 | $28,000 | -44.0% | 406 | -41.6% | 0.00% | – |
| Q2 2020 | $50,000 | +150.0% | 695 | +18.0% | 0.00% | – |
| Q1 2020 | $20,000 | – | 589 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 900,844 | $136,181,000 | 79.57% |
| RP Management, LLC | 1,111,111 | $167,967,000 | 77.60% |
| JET CAPITAL INVESTORS L P | 1,707,500 | $258,942,000 | 53.95% |
| Alpine Global Management, LLC | 373,999 | $56,537,000 | 13.23% |
| Chicago Capital Management, LLC | 154,585 | $23,443,000 | 12.75% |
| FIFTH LANE CAPITAL, LP | 140,000 | $21,164,000 | 11.03% |
| UBS OCONNOR LLC | 3,784,482 | $572,100,000,000 | 10.85% |
| Eversept Partners, LP | 637,139 | $96,316,303 | 8.35% |
| EQUITEC PROPRIETARY MARKETS, LLC | 187,100 | $28,284,000 | 7.45% |
| HARVEST MANAGEMENT LLC | 48,503 | $7,332,000 | 5.92% |